Table I.
Summary of clinical characteristics.
| ESR, mm/h | CRP, mg/l | Hb, g/l | PLT, 109/l | WB, 109/l | PDN, mg/day | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient no | Sex | Age, years | TAC, mg/day | Baseline | Last visit | Baseline | Last visit | Baseline | Last visit | Baseline | Last visit | Baseline | Last visit | Baseline | Last visit |
| 1 | M | 13.0 | 2.0–3.0 | 68.0 | 12.0 | 160.0 | 8.0 | 117.0 | 125.0 | 433.0 | 242.0 | 37.1 | 7.3 | 60.0 | 2.5 |
| 2 | F | 11.5 | 2.0–3.0 | 72.0 | 5.0 | 119.0 | 8.0 | 102.0 | 104.2 | 460.0 | 249.0 | 37.0 | 8.3 | 60.0 | 5.0 |
| 3 | M | 11.0 | 2.0–3.0 | 78.0 | 4.0 | 160.0 | 8.0 | 117.0 | 124.0 | 319.0 | 316.0 | 28.1 | 6.9 | 60.0 | 0.0 |
| 4 | F | 5.5 | 1.0–2.0 | 58.0 | 9.0 | 67.0 | 8.0 | 91.2 | 102.2 | 326.0 | 233.0 | 10.7 | 6.2 | 24.0 | 0.0 |
| 5 | F | 9.5 | 1.0–2.0 | 38.0 | 3.0 | 102.0 | 8.0 | 127.0 | 138.0 | 560.0 | 364.0 | 20.5 | 7.3 | 30.0 | 0.0 |
| 6 | M | 14.0 | 1.0–2.0 | 93.0 | 1.0 | 160.0 | 8.0 | 98.2 | 116.0 | 403.0 | 117.0 | 22.5 | 5.5 | 60.0 | 0.0 |
| Mean ± SD | – | 10.8±3.0 | – | 67.8±18.7 | 5.7±4.1a | 128.0±38.9 | 8.0±0a | 108.7±13.7 | 118.2±13.6 | 416.8±90.1 | 253.5±84.0a | 26.0±10.2 | 6.9±1.0a | 49.0±17.1 | 1.3±2.1a |
TAC, tacrolimus; baseline, measurement prior to treatment with TAC; last visit, measurement following treatment with TAC for 12 months; M, male; F, female; ESR, erythrocyte sedimentation rate; CRP, C reactive protein; Hb, hemoglobin; PLT, platelet; WB, white blood cell; PDN, prednisolone; SD, standard deviation.
a
P<0.05 vs. baseline.